Alterations in thyroid function among the different polycystic ovary syndrome phenotypes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gynecological Endocrinology

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/09513590.2013.829445PMID 23957782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.

  2011cited by this paper
• Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome.

  2011cited by this paper
• Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome

  2011cited by this paper
• The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.

  2011cited by this paper
• Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.

  2009cited by this paper
• Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.

  2009cited by this paper
• TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients

  2009cited by this paper
• Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy

  2007cited by this paper
• Genetic and environmental origins of obesity relevant to reproduction.

  2006cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries

  1993cited by this paper
• Subclinical hypothyroidism: a determinant of polycystic ovary syndrome.

  1993cited by this paper
• Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome

  1989cited by this paper
• Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.

  1987cited by this paper
• Amenorrhea associated with bilateral polycystic ovaries

  1935cited by this paper

• Use of myo-inositol in treatment of subclinical hypothyroidism

  2026cites this paper
• Prevalence of subclinical hypothyroidism in polycystic ovary syndrome and its impact on insulin resistance: a systematic review and meta-analysis

  2025cites this paper
• Metformin and myo-inositol: A comparative analysis.

  2025cites this paper
• Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism

  2025cites this paper
• Serum Levels of Angiopoietin-Like Protein 6 (ANGPTL6) in Iranian Women with Polycystic Ovary Syndrome

  2025cites this paper
• Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience

  2024cites this paper
• A Comprehensive Review of Thyroid Dysfunction: Hidden Player in Male Infertility

  2024cites this paper
• Comparative Retrospective Analysis of Clinical and Hormonal Profiles in PCOS Patients with and Without Infertility

  2024cites this paper
• Is thyroid function associated with polycystic ovary syndrome? A bidirectional Mendelian randomization study

  2024influential citation
• Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels

  2023cites this paper
• Polycystic Ovary Syndrome, Subclinical Hypothyroidism, the Cut-Off Value of Thyroid Stimulating Hormone; Is There a Link? Findings of a Population-Based Study

  2023cites this paper
• Differences in levothyroxine action on thyroid autoimmunity and hypothalamic–pituitary–thyroid axis activity between metformin‐ and myo‐inositol‐treated women with autoimmune subclinical hypothyroidism

  2022cites this paper
• Myo-Inositol Enhances the Inhibitory Effect of Metformin on Gonadotropin Levels in Postmenopausal Women

  2022cites this paper
• The impact of vitamin D on thyroid autoimmunity and hypothalamic–pituitary–thyroid axis activity in myo‐inositol‐treated and myo‐inositol‐naïve women with autoimmune thyroiditis: A pilot study

  2022cites this paper
• Myoinositol in Autoimmune Thyroiditis

  2022cites this paper
• The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management

  2021cites this paper
• Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Preliminary Study

  2021cites this paper
• Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis: How Far Is Our Understanding?

  2021cites this paper
• The Influence of Oxidative Stress on Thyroid Diseases

  2021cites this paper
• The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome

  2021cites this paper
• Relación entre hipotiroidismo y síndrome de ovario poliquístico

  2021cites this paper
• Are Dietary Indices Associated with Polycystic Ovary Syndrome and Its Phenotypes? A Case-Control Study

  2020cites this paper
• High Thyroid Stimulating Hormone Level Is Associated With Hyperandrogenism in Euthyroid Polycystic Ovary Syndrome (PCOS) Women, Independent of Age, BMI, and Thyroid Autoimmunity: A Cross-Sectional Analysis

  2019cites this paper
• Infertilidad por síndrome de ovario poliquístico en mujeres del municipio Las Tunas

  2019cites this paper
• Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients

  2018cites this paper
• Myo-inositol in autoimmune thyroiditis, and hypothyroidism

  2018cites this paper
• Reproductive Outcomes After a Childhood and Adolescent Young Adult Cancer Diagnosis in Female Cancer Survivors: A Systematic Review and Meta-Analysis

  2018cites this paper
• Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.

  2018cites this paper
• Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

  2018influential citation
• Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study

  2018cites this paper
• Myo-inositol and selenium in subclinical hypothyroidism

  2018cites this paper
• Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.

  2017cites this paper
• Subclinical Hypothyroidism Impact on the Characteristics of Patients with Polycystic Ovary Syndrome. A Meta-Analysis of Observational Studies

  2017cites this paper
• Thyroid disorders in polycystic ovary syndrome.

  2017cites this paper
• High-normal thyroid stimulating hormone is a predictor of metabolic syndrome among young polycystic ovary syndrome women

  2016cites this paper
• IS SUBCLINICAL HYPOTHYROIDISM IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME ASSOCIATED WITH BMI?

  2016cites this paper
• [High frequency of thyroid abnormalities in polycystic ovary syndrome].

  2015cites this paper
• Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.

  2014cites this paper